Int J Oral Implantol (Berl). 2021 Nov 2;14(4):421-430.
To prospectively assess marginal bone loss and implant survival with Astra Tech (Dentsply Sirona, Charlotte, NC, USA) (group A) and Brånemark (Nobel Biocare, Zurich, Switzerland) (group B) implants in a split-mouth study conducted over a 20-year follow-up period.
A total of 95 implants (n = 50, group A and n = 45, group B) were randomly placed in the left or right side of the maxilla or mandible in 18 patients. Clinical and radiographic examinations were performed, and results were reported at 5, 10, 15 and 20 years after insertion of the prosthesis.
Ten patients were followed up for 20 years (n = 26 implants, group A and n = 25 implants, group B). No implant loss or prosthetic failures were observed. After 20 years of follow-up, no significant differences in marginal bone loss were found between both implant groups (P = 0.25). The proportion of marginal bone loss ≥ 0.5 mm was not significantly different between implant types (P > 0.05), and no statistically significant relationships were found between marginal bone loss and time (P ≥ 0.05). More specifically, there was no significant difference in marginal bone level between year 20 and baseline in group A (P = 0.70), whereas a difference of 0.5 to 1.0 mm was found in group B (P = 0.15).
After 20 years of follow-up, marginal bone loss around screw-shaped titanium implants was clinically insignificant. Furthermore, no significant differences in survival and marginal bone loss were found between group A and B implants over the follow-up period.
前瞻性评估 AstraTech(登士柏西诺德,美国北卡罗来纳州夏洛特)(A 组)和 Brånemark(诺保科,瑞士苏黎世)(B 组)种植体在长达 20 年的随访期内的边缘骨丢失和种植体存活率。
18 名患者的上颌或下颌骨的左侧或右侧随机放置了总共 95 个种植体(n = 50,A 组,n = 45,B 组)。在种植体插入后 5、10、15 和 20 年进行了临床和放射学检查,并报告了结果。
10 名患者随访 20 年(n = 26 个种植体,A 组和 n = 25 个种植体,B 组)。未观察到种植体丢失或修复体失败。20 年随访后,两组种植体的边缘骨丢失无显著差异(P = 0.25)。边缘骨丢失≥0.5 毫米的种植体类型比例无显著差异(P > 0.05),且边缘骨丢失与时间之间无统计学显著关系(P ≥ 0.05)。更具体地说,A 组在第 20 年和基线之间的边缘骨水平没有显著差异(P = 0.70),而 B 组的差异为 0.5 至 1.0 毫米(P = 0.15)。
20 年随访后,螺钉状钛种植体周围的边缘骨丢失在临床上可以忽略不计。此外,在随访期间,A 组和 B 组种植体的存活率和边缘骨丢失无显著差异。